Page last updated: 2024-10-21

1,2-dioctanoylglycerol and Leukemia

1,2-dioctanoylglycerol has been researched along with Leukemia in 2 studies

1,2-dioctanoylglycerol: functions as bioregulator of protein kinase C in human platelets

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berkovic, D1
Berkovic, K1
Fleer, EA1
Eibl, H1
Unger, C1
Jung, LK1
Fu, SM1

Other Studies

2 other studies available for 1,2-dioctanoylglycerol and Leukemia

ArticleYear
Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:4

    Topics: Antineoplastic Agents; Cell Division; Cell Membrane; Cytosol; Diglycerides; Dose-Response Relationsh

1994
Effect of tumor promoter 12-O-tetradecanoyl-phorbol 13-acetate on CD 7 expression by T lineage cells.
    European journal of immunology, 1988, Volume: 18, Issue:5

    Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Depression, Chemical; Diglycerides;

1988